Diagnos Laboratorium Utama PT Tbk (DGNS) - Total Liabilities

Latest as of June 2025: Rp110.07 Billion IDR ≈ $6.45 Million USD

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has total liabilities worth Rp110.07 Billion IDR (≈ $6.45 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore DGNS cash generation efficiency to assess how effectively this company generates cash.

Diagnos Laboratorium Utama PT Tbk - Total Liabilities Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Diagnos Laboratorium Utama PT Tbk to evaluate the company's liquid asset resilience ratio.

Diagnos Laboratorium Utama PT Tbk Competitors by Total Liabilities

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their total liabilities.

Company	Country	Total Liabilities
Cordoba Minerals Corp V:CDB	Canada	CA$7.61 Million
RENN Fund Inc NYSE MKT:RCG	USA	$95.59K
Intikeramik Alamasri Industri JK:IKAI	Indonesia	Rp443.90 Billion
GreenPro Capital Corp NASDAQ:GRNQ	USA	$1.79 Million
Premium Catering (Holdings) Limited NASDAQ:PC	USA	$5.88 Million
Lighting and Equipment Public Company Limited BK:L&E	Thailand	฿1.95 Billion
Bankers Investment Trust LSE:BNKR	UK	GBX134.76 Million
Israel China Biotechnology (ICB) Ltd TA:ICB	Israel	ILA4.11 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Diagnos Laboratorium Utama PT Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DGNS stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diagnos Laboratorium Utama PT Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual total liabilities of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	Rp103.89 Billion ≈ $6.09 Million	+36.91%
2023-12-31	Rp75.88 Billion ≈ $4.45 Million	+157.17%
2022-12-31	Rp29.51 Billion ≈ $1.73 Million	-26.57%
2021-12-31	Rp40.18 Billion ≈ $2.35 Million	+19.92%
2020-12-31	Rp33.51 Billion ≈ $1.96 Million	+162.55%
2019-12-31	Rp12.76 Billion ≈ $747.85K	+14.23%
2018-12-31	Rp11.17 Billion ≈ $654.69K	+112.02%
2017-12-31	Rp5.27 Billion ≈ $308.79K	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$19.48 Million

Rp332.50 Billion IDR

Market Cap Rank

#25106 Global

#548 in Indonesia

Share Price

Rp266.00

Change (1 day)

-4.32%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74